Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.
Frequently asked questions
What sector does Endurance RP Ltd (0575) operate in?
Endurance RP Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Endurance RP Ltd (0575) current stock price?
As of the latest data, Endurance RP Ltd stock price is HK$0.85, with a previous close of HK$0.85.
What is Endurance RP Ltd (0575) current market capitalization?
Endurance RP Ltd market cap is approximately 248.04 million.
What is Endurance RP Ltd (0575) EBITDA?
Endurance RP Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.38 million.
Does Endurance RP Ltd (0575) pay dividends?
No. Endurance RP Ltd does not pay a dividend.
What is Endurance RP Ltd (0575) beta (volatility) score?
Endurance RP Ltd has a beta of 1.121, meaning its volatility is roughly in line with the market.
